ScienceMedia, the leader in life sciences and clinical trial education, has again demonstrated its commitment to innovation by launching a new version of SMi Trial , the company’s risk-based protocol training solution, and expanding the ScienceMedia team with the addition of a new Product Director, Robert Geckeler
| SAN DIEGO, March 3, 2021 /PRNewswire/ -- ScienceMedia, the leader in life sciences and clinical trial education, has again demonstrated its commitment to innovation by launching a new version of SMi Trial, the company’s risk-based protocol training solution, and expanding the ScienceMedia team with the addition of a new Product Director, Robert Geckeler, and Sr. Marketing Manager, Jen Pfau. Debuted at the Virtual Summit for Clinical Ops Executives conference on March 2, this recent release of SMi Trial significantly enhances the user interface with improved lesson organization and navigation to allow busy study teams and site staff to more easily identify and complete training modules. It also includes security and performance enhancements, with a particular focus on streamlining administrative controls to improve flexibility of training assignments and reporting. The new flexible hierarchy supports multiple configurations based on roles to ease the burden on sponsors who must ensure compliance across a diverse population of internal and external teams. Regarding the release, Geckeler stated that “It is our goal to regularly upgrade the user experience on SMi Trial. Through this release, and through plans for future updates that incorporate both incremental and pioneering changes to our content and platform, we seek to increase the efficacy of SMi Trial in the support of site engagement and performance.” These additions to SMi Trial and to the ScienceMedia team are in keeping with our goal of continuing to lead the way in providing engaging training that mitigates protocol compliance risk. With this update, ScienceMedia also gains two seasoned professionals to drive product development and customer engagement. With more than 25 years of experience in the pharmaceutical industry and clinical development, Geckeler, ScienceMedia’s Product Director, will spearhead SMi Trial’s continued innovation and user experience. Additionally, as the new Sr. Marketing Manager, Pfau, who has been thriving in the e-learning/publishing and content marketing space for more than 17 years, will be focusing on meaningful customer engagement and creative brand messaging for ScienceMedia. ScienceMedia CEO Mark Surles, PhD, shared that he is “thrilled to see our ScienceMedia team continue to flourish in producing quality upgrades for the pharma industry. Acquiring leaders, Rob and Jen, who are experts in their fields, will only bring more excitement and impactful innovation to the future of SMi Trial.” To learn more about how SMi Trial is paving the way in mitigating clinical risk, visit sciencemedia.com/trial. About ScienceMedia
SOURCE ScienceMedia |
View original content:
